![](/accounts/sepsisalliance/images/logo.png)
CorMedix Sponsored Session: Reducing Risk of CRBSIs in Hemodialysis Patients: A Multi-Disciplinary Approach
Includes a Live Web Event on 04/30/2025 at 12:45 PM (PDT)
Description:
In this sponsored session, gain an understanding of the patient journey for people living with end stage kidney disease (ESKD) who require hemodialysis through a central venous catheter (CVC) and have experienced a catheter related blood stream infection (CRBSI). Learn about the risks associated with CRBSIs in patients on hemodialysis, including the role of AMR and sepsis. Opportunities for prevention, including the clinical data for a recent FDA approved catheter lock solution, and ways for healthcare teams to work together to improve patient outcomes will also be discussed.
This session is part of the Sepsis Alliance AMR Conference 2025.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Session Supporter:
Sepsis Alliance gratefully acknowledges the support of this session provided by CorMedix.
![Speaker image](https://c0ea946ea14de934f725-1840b682e23387c2aca618bb13b142d8.ssl.cf2.rackcdn.com/sepsisalliance_a107a11086372d3284219b141c649725.jpeg)
Celina Medina
Speaker Advocate
Celina Medina's journey started at the age of 18 months when she was diagnosed with nephrotic syndrome. She spent her childhood and early adult life in and out of hospitals with declining kidney function until she progressed to requiring hemo- and peritoneal- dialysis. She received her first gift of life from her brother at the age of twenty-six. Due to rejection of her transplant, she had to reinitiate peritoneal dialysis. During that transition, she required a CVC and developed a severe catheter related blood stream infection (CRBSI), against which her initial antibiotics were not effective. Thankfully, there were alternative antibiotics available to treat her infection and she was able to move on to peritoneal dialysis for twelve years until she was able to receive a second transplant. She now focuses on advocacy work and improving care of patients with kidney disease.
![Speaker image](https://c0ea946ea14de934f725-1840b682e23387c2aca618bb13b142d8.ssl.cf2.rackcdn.com/sepsisalliance_1b085e5e8bd28086c031c6c3069c49bb.jpg)
Payal Patel, MD
System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor
Intermountain Health
Payal Patel, MD, is an associate professor at Intermountain Health and the systemwide medical director of antimicrobial stewardship. She is an infectious diseases physician and is passionate about improving patient safety and antimicrobial stewardship. She serves on the Presidential Advisory Council on Combatting Antibiotic Resistance and has worked to help develop antimicrobial stewardship programs in several countries including India, Japan, and Italy.